Applied BioCode Corporation (6598.TW) TAI

24.10

-0.2(-0.82%)

Updated at June 03 01:30PM

Currency In TWD

Key Executives

Name	Title	Pay	Year Born
Winston Z.	Founder, Chief Executive Officer, President & Director	42,000	N/A
Jaca Liang-Kai Huang	Chief Financial Officer & Corporate Governance Officer	6.17M	N/A
Beth Laderman	Chief Scientific Officer	0	N/A
Jim Leigh	Senior Vice President of Sales	0	N/A
Ingrid Joseph	Administration Division Director	0	N/A
Ruei-E Tang	Administration Division Director	0	N/A
Parisa Hanachi	Vice President of Marketing	0	N/A
Yu-Tsung Chou	Chief Information Officer	0	N/A
Zhao Gu Chen	Accounting Director	0	N/A

Name

Title

Pay

Year Born

Winston Z.

Founder, Chief Executive Officer, President & Director

42,000

N/A

Jaca Liang-Kai Huang

Chief Financial Officer & Corporate Governance Officer

6.17M

N/A

Beth Laderman

Chief Scientific Officer

N/A

Jim Leigh

Senior Vice President of Sales

N/A

Ingrid Joseph

Administration Division Director

N/A

Ruei-E Tang

Administration Division Director

N/A

Parisa Hanachi

Vice President of Marketing

N/A

Yu-Tsung Chou

Chief Information Officer

N/A

Zhao Gu Chen

Accounting Director

N/A

Description

Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. In addition, It develops assays, such as BioCode SARS-CoV-2 Assay, a high volume automated nucleic acid multiplex assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; BioCode Respiratory Pathogen Panels, which simultaneously detects and differentiates the presence of 17 respiratory pathogens in nasopharyngeal swabs; BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and MDx assays pipeline for various molecular tests. Further, the company offers fungal pathogen analyte specific reagents; human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Additionally, the company provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. Applied BioCode Corporation is based in Santa Fe Springs, California.